Adverum Biotech
Sherry (Xiangyan) Tong is an accomplished clinical trial manager with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as a Senior Clinical Trial Manager at Adverum Biotechnologies, Inc. since September 2018, Sherry previously held roles at Corcept Therapeutics, Iovance Biotherapeutics, Inc., Pharmacyclics, and Nodality Inc., progressing from Clinical Trial Assistant to Senior Clinical Research Associate. Sherry holds a Doctor of Philosophy (PhD) in Molecular Biosciences from The University of Kansas, a Master's degree in Clinical Research from UC San Diego, and a Bachelor's degree in Biochemistry from Nankai University.
Adverum Biotech
9 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.